TLDR:
- Terumo Corporation has established a Corporate Venture Capital (CVC) organization called “Terumo Ventures” to lead the group’s venture investments.
- Terumo Ventures will invest $75 million over the next five years in early-stage companies primarily focused on cardiovascular disease treatment, chronic disease treatment, and digital technologies.
Terumo Corporation has announced the establishment of “Terumo Ventures,” a Corporate Venture Capital (CVC) organization within Terumo Americas Holding, Inc. This new department will lead the group’s venture investments and operate in global innovation hubs such as Massachusetts and California in the United States. Terumo Ventures plans to invest $75 million over the next five years in early-stage companies, with a focus on cardiovascular disease treatment, chronic disease treatment, and digital technologies.
By investing in start-ups, Terumo aims to enhance its access to innovative technologies and business ideas, promote open innovation, and create synergies with its internal R&D efforts. The company has been involved in medtech start-ups by investing in venture capital funds in the United States and China since 2013. With the establishment of the CVC, Terumo seeks to increase its agility in identifying and executing venture investments, accelerating the acquisition of cutting-edge technologies and developing a robust M&A target pipeline for future growth.
With its 5-Year Growth Strategy “GS26” and vision of “From Devices to Solutions,” Terumo is dedicated to delivering innovative solutions to medical challenges. In line with this, the company introduced a new director position for innovation in April 2024 to manage innovation-related functions like R&D, intellectual property, clinical development, digital transformation, and venture investment. Moving forward, Terumo plans to strengthen its ability to create innovation through internal development and partnerships to expand the value it provides to society.
For more information on Terumo Ventures, visit their website.
